A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.
FILE PHOTO: A woman holds a small bottle labeled with a"Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
The drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has killed more than half a million so far. The following rivals have released early-stage trial data for potential COVID-19 vaccines, or are expected to publish soon:Moderna Inc said in May that its vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, though doubts remain over whether the data is predictive of real-life success.
The World Health Organization’s chief scientist said last week that AstraZeneca’s vaccine was probably the world’s leading candidate and the most advanced in terms of development.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
China reports 19 new COVID-19 cases, including seven in BeijingChina on Tuesday reported 19 new coronavirus cases in the mainland for June 29, up from 12 a day earlier, the health authority said. There were no new deaths.
Weiterlesen »
19 business owners share their silver linings of the COVID-19 pandemic - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »
COVID-19 vaccine: Pfizer vaccine shows potential in early human trialsA Pfizer COVID-19 vaccine has shown potential and was found to be well tolerated in early-stage human trials, company says. The drug is one of 17 being tested on humans, and is the 4th early-stage COVID-19 drug to show promise in human testing.
Weiterlesen »
Inovio Reports Positive Early-Stage Trial Results for Covid-19 VaccineThe drugmaker reported positive preliminary results from the first-phase trial of its vaccine candidate for the new coronavirus, citing good indications regarding the vaccine’s safety and potential to protect against the virus.
Weiterlesen »
Covid-19 vaccine from Pfizer and BioNTech shows 'encouraging' data in early studyA Covid-19 vaccine candidate has yielded positive data in early tests, according to findings released by US drugmaker Pfizer and Germany's BioNTech. Follow live updates:
Weiterlesen »
Inovio's stock falls as it discloses early-stage data for its COVID-19 vaccine candidateShares of Inovio Pharmaceuticals Inc. undefined tumbled 10.8% in premarket trading on Tuesday after the company said its COVID-19 vaccine candidate was...
Weiterlesen »